康乐卫士：三价和九价HPV疫苗临床试验暂停

Core Viewpoint - The company is facing a suspension of its clinical trials for its HPV vaccines due to overdue payments for clinical trial funding and a shortage of on-site research funds [1] Group 1 - The Shanxi Provincial Center for Disease Control and Prevention has suspended the company's Phase III clinical trials for the trivalent HPV vaccine and the nine-valent HPV vaccine (female indications) [1] - The Jiangsu Provincial Center for Disease Control and Prevention has also suspended the company's Phase III clinical trial for the nine-valent HPV vaccine (female indications) [1]